8-K: dMY Squared Faces NYSE Delisting Threat Over Delayed 10-Q
Notice of Non-Compliance
dMY Squared Technology Group, Inc. received a notice from NYSE American for failing to timely file its Second Quarter 10-Q, risking potential delisting.
Summary
- dMY Squared Technology Group, Inc. (DMYY) received a notice from NYSE American on August 20, 2025, for non-compliance with Section 1007 of the NYSE American Company Guide.
- The non-compliance is due to the company's failure to timely file its Quarterly Report on Form 10-Q for the three and six months ended June 30, 2025 (Second Quarter 10-Q).
- The notice has no immediate effect on the listing or trading of the company's securities.
- The company has until February 19, 2026, to file the Second Quarter 10-Q and regain compliance.
- If compliance is not regained by February 19, 2026, the company may request an additional six-month extension, potentially until August 19, 2026.
- Failure to regain compliance could lead to the delisting of the company's securities from the NYSE American.
- The company is working diligently to complete and file the Second Quarter 10-Q as soon as practicable.
- A press release announcing the receipt of the notice was issued on August 22, 2025.
Sentiment
Score: 3
Explanation: The filing indicates a significant regulatory non-compliance issue (delayed 10-Q and NYSE notice), which carries a material risk of delisting. While the company states it is working to resolve it, the situation is negative and creates uncertainty for investors.
Positives
- The notice has no immediate effect on the listing or trading of the company's securities.
- The company has a defined period, initially six months, to regain compliance.
- Management states they are working diligently to complete the filing.
Negatives
- Received a notice of non-compliance from NYSE American.
- Failed to timely file the Second Quarter 10-Q.
- Faces the risk of delisting from NYSE American if compliance is not regained.
- Uncertainty exists regarding the NYSE American granting an extension if needed, or the company's ability to regain compliance within any extension period.
Risks
- Preparation of the company's financial statements for the fiscal quarter ended June 30, 2025, may take longer than anticipated.
- Inability to regain and maintain compliance with NYSE American listing requirements.
- Adverse effects on the company's business related to the disclosures made in this report or the initiation of new legal proceedings.
- Volatility of the company's stock price due to the non-compliance and potential delisting.
- General business, financial, and accounting risks as discussed in the Annual Report on Form 10-K for the year ended December 31, 2024.
Future Outlook
The company intends to file its Second Quarter 10-Q as soon as practicable to regain compliance with NYSE American listing rules. However, there is no assurance that the NYSE American will accept any request for an extension or that the company will be able to regain compliance within any granted period.
Management Comments
- "The Company is working diligently to complete its Second Quarter 10-Q."
- "The Company intends to file the Second Quarter 10-Q as soon as practicable to regain compliance with the Rule."
Industry Context
This event highlights the strict regulatory compliance requirements for publicly traded companies, particularly Special Purpose Acquisition Companies (SPACs), which are under increased scrutiny. Timely financial reporting is a fundamental expectation for maintaining market integrity and investor confidence. Failure to comply, even for a blank check company, can lead to significant consequences like delisting, impacting its ability to complete a business combination.
Comparison to Industry Standards
- Timely filing of periodic financial reports (e.g., Form 10-Q) is a universal standard for all listed companies on major exchanges like NYSE American, NASDAQ, and others globally.
- Non-compliance with filing deadlines, as seen with dMY Squared, is a breach of fundamental listing rules, similar to issues faced by companies that fail to meet reporting obligations.
- The NYSE American's process of issuing a notice and providing a cure period (six months, with a potential extension) is standard practice across exchanges to allow companies to rectify non-compliance before initiating delisting procedures.
Stakeholder Impact
- Shareholders face increased risk of stock price volatility and potential delisting, which could severely impair liquidity and value.
- As a blank check company, direct impact on customers/suppliers is minimal, but the company's ability to complete a business combination could be hampered, indirectly affecting potential future partners.
Next Steps
- Complete and file the Second Quarter 10-Q as soon as practicable.
- Regain compliance with NYSE American Section 1007.
- Potentially submit a request to NYSE American for an extension if the initial six-month period is insufficient.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Fiscal year end for which Annual Report on Form 10-K was filed on April 3, 2025. |
| 2025-04-03 | Date Annual Report on Form 10-K for the year ended December 31, 2024, was filed with the SEC. |
| 2025-06-30 | End of the three and six months period for the delayed Second Quarter 10-Q. |
| 2025-08-15 | Date Form 12b-25 was filed, disclosing the need for additional time to file the Second Quarter 10-Q. |
| 2025-08-20 | Date the company received the notice of non-compliance from NYSE American. |
| 2025-08-22 | Date the company issued a press release announcing the receipt of the notice and the date this Form 8-K was signed. |
| 2026-02-19 | Deadline to file the Second Quarter 10-Q to regain compliance with NYSE American listing standards (six months from due date). |
| 2026-08-19 | Potential extended deadline to file the Second Quarter 10-Q if an additional six-month extension is granted by NYSE American. |
Recommendation
sellThe company, a blank check company (SPAC), has failed to meet a fundamental regulatory requirement by delaying its quarterly financial report, leading to a formal non-compliance notice and a delisting threat from NYSE American. This significantly increases the risk profile for investors. While management states they are working to resolve it, the uncertainty surrounding regaining compliance, potential further delays, and the severe consequence of delisting make the stock highly speculative and risky. For a seasoned investor, this signals a fundamental operational and governance issue that warrants exiting the position until compliance is firmly re-established and the company's SPAC mission is back on track.
Keywords
dMY Squared Technology Group, DMYY, NYSE American, delisting, Form 10-Q, SEC filing, non-compliance, quarterly report, SPAC, blank check company
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.